Maternal care for anti-D [Rh] antibodies, unspecified trimester (fetus 2)
ICD-10 O36.0192 is a billable code used to indicate a diagnosis of maternal care for anti-d [rh] antibodies, unspecified trimester (fetus 2).
Maternal care for anti-D [Rh] antibodies is crucial in managing pregnancies where the mother has developed antibodies against Rh-positive blood. This condition can lead to hemolytic disease of the fetus and newborn (HDFN), which can cause serious complications such as fetal growth restriction, fetal distress, and even stillbirth. The management of this condition involves careful monitoring of the fetus through ultrasound assessments to evaluate growth and well-being, as well as maternal blood tests to assess antibody levels. In cases where fetal distress is detected, interventions may include early delivery or intrauterine transfusions. The unspecified trimester designation indicates that the care provided could occur at any point during the pregnancy, necessitating ongoing surveillance and potential interventions to ensure the health of both the mother and the fetus.
Detailed records of maternal health, fetal assessments, and any interventions performed.
Routine monitoring of Rh-negative mothers, management of fetal growth restriction, and addressing fetal distress.
Ensure accurate documentation of all maternal and fetal assessments, including ultrasound findings and laboratory results.
Comprehensive documentation of high-risk factors, including maternal history and fetal monitoring.
Management of pregnancies complicated by Rh incompatibility, including intrauterine transfusions.
Focus on detailed tracking of fetal development and maternal antibody levels, as well as interdisciplinary communication.
Used for routine monitoring of fetal growth and well-being in pregnancies complicated by anti-D antibodies.
Document the reason for the ultrasound and findings related to fetal growth and distress.
Obstetricians should ensure that ultrasound reports are detailed and correlate with maternal antibody levels.
Coding O36.0192 is essential for tracking pregnancies complicated by anti-D antibodies, which can lead to serious fetal complications. Accurate coding ensures that appropriate care is provided and that healthcare providers are reimbursed for the services rendered.
